AGP Picks
View all

Alternative Medicine Times
Provided by AGP

Alternative Medicine Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

Press releases published on August 10, 2026

Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
Aug. 10, 2026

Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston

Indeterminate GlobeNewswire
Metabio Advances Global Preventive Healthcare with Integrated AI-Powered Bioresonance Ecosystem
Aug. 10, 2026

Metabio Advances Global Preventive Healthcare with Integrated AI-Powered Bioresonance Ecosystem

Indeterminate GlobeNewswire
Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)
Aug. 10, 2026

Zealand Pharma - Transactions related to share buy-back program (week 32, 2026)

Indeterminate GlobeNewswire
New research explores how data can help detect disease earlier and improve patient care
Aug. 10, 2026

New research explores how data can help detect disease earlier and improve patient care

Indeterminate GlobeNewswire
PLNT Investors Have Opportunity to Lead Planet Fitness, Inc. Securities Fraud Lawsuit with SBS Law
Aug. 10, 2026

PLNT Investors Have Opportunity to Lead Planet Fitness, Inc. Securities Fraud Lawsuit with SBS Law

Indeterminate GlobeNewswire
PLNT UPCOMING DEADLINE: Levi & Korsinsky Alerts Planet Fitness, Inc. Stockholders of Securities Class Action - Contact the Firm
Aug. 10, 2026

PLNT UPCOMING DEADLINE: Levi & Korsinsky Alerts Planet Fitness, Inc. Stockholders of Securities Class Action - Contact the Firm

Indeterminate GlobeNewswire
NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears
Aug. 10, 2026

NeOnc Heads into a High-Stakes Week as Highly Anticipated NEO100 Phase 2a Data Readout Nears

Indeterminate GlobeNewswire
The 2026 Historic Hotels Worldwide® Annual Awards of Excellence Nominee Finalists are Announced
Aug. 10, 2026

The 2026 Historic Hotels Worldwide® Annual Awards of Excellence Nominee Finalists are Announced

Indeterminate GlobeNewswire
ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11)
Aug. 10, 2026

ITM Receives Complete Response Letter for ¹⁷⁷Lu-edotreotide (ITM-11)

Indeterminate GlobeNewswire
Momcozy Brings 'Breathe & Breastfeed' to Malaysia, Launching Wellness 1 to Support Every Feeding Journey
Aug. 10, 2026

Momcozy Brings 'Breathe & Breastfeed' to Malaysia, Launching Wellness 1 to Support Every Feeding Journey

Indeterminate EIN Presswire
Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage
Aug. 10, 2026

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Indeterminate GlobeNewswire
Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics
Aug. 10, 2026

Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics

Indeterminate GlobeNewswire
PerfectServe Ushers in New Era of AI in Voice with Intelligent Answering powered by ConnectiveIQ
Aug. 10, 2026

PerfectServe Ushers in New Era of AI in Voice with Intelligent Answering powered by ConnectiveIQ

Indeterminate GlobeNewswire
Boost Mobile and University of Miami Athletics Put Canes Fans on the Roster
Aug. 10, 2026

Boost Mobile and University of Miami Athletics Put Canes Fans on the Roster

Indeterminate GlobeNewswire
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma
Aug. 10, 2026

Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma

Indeterminate GlobeNewswire
CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway
Aug. 10, 2026

CMS Proposed 2027 Medicare Policy Continues Recognition of the FDA’s Section 351 Biologic Pathway

Indeterminate GlobeNewswire
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
Aug. 10, 2026

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

Indeterminate GlobeNewswire
Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity
Aug. 10, 2026

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

Indeterminate GlobeNewswire
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2026 Financial Results on August 14, 2026
Aug. 10, 2026

TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Second Quarter 2026 Financial Results on August 14, 2026

Indeterminate GlobeNewswire
OZOP Energy Solutions, Inc. Highlights Ballislife Drink's Partnership with Detroit Pistons Star Jalen Duren
Aug. 10, 2026

OZOP Energy Solutions, Inc. Highlights Ballislife Drink's Partnership with Detroit Pistons Star Jalen Duren

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Alternative Medicine Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.